Измени свой мозг - изменится и тело!
Шрифт:
Haines, A.P., Imeson, J.D., Meade, T.W. 1987. Phobic anxiety and ischaemic heart disease. British Medical Journal 295:297–299.
Kawachi, I., Colditz, G.A., Ascherio, A., Rimm, E.B., Giovannucci, E., Stampfer, M.J., Willett, W.C. 1994. Prospective study of phobic anxiety and risk of coronary heart disease. Circulation 89:1992–1997.
Kawachi, I., Sparrow, D., Vokonas, P.S., Weiss, S.T. 1994. Symptoms of anxiety and risk of coronary heart disease: The Normative Aging Study. Circulation 90:2225–2229.
Kawachi, I., Sparrow, D. Vokonas, P.S., Weiss, S.T. 1995. Decreased heart rate variability in men with phobic anxiety. American Journal of Cardiology 75:882–885.
Kristal-Boneh, E. Raifel, M. Froom, P., Ribak, J. 1995. Heart rate variability in health and disease. Scandinavian Journal of Work, Environment & Health 21:85–95.
Lavi, T., Karasik, A., Koren-Morag, N., Kanety, H. Feinberg, M., Shecther, M. 2009. The acute effect of various glycemic index dietary carbohydrates on endothelial function in nondiabetic overweight and obese subjects. Journal of the American College of Cardiology 53:2283-2287
McCraty, R., Atkinson, M., Tiller, W., Rein, G. Watkins, A.D. 1995. The effects of emotions on short-term power spectrum analysis of heart rate variability. American Journal of Cardiology 76(14): 1089–1093.
Mendoza, I., et al. Sudden death: the anniversary effect. American College of Cardiology Meeting 2008; Abstract 1029-100.
Miller, M. Mangano, C., Park, Y., Goel, R., Plotnick, G.D., Vogel, R.A. 2006. Impact of cinematic viewing on endothelial function. Heart 92(2):261-2.
Mittleman, M.A., Maclure, M. Sherwood, J.B., Mulry, R.P., Tofler, G.H., Jacobs, S.C., Friedman, R., Benson, H. Muller, J.E. 1995. Triggering of acute myocardial infarction onset by episodes of anger. Circulation 92:1720–1725.
Neki, N.S., Singh, R.B., Rastogi, S.S. 2004. How brain influences neuro- cardiovascular dysfunction. Journal of Assocication of Physicians of India. 52:223-30.
Novoa, R., Hammonds, T., 2008. Clinical hypnosis for reduction of atrial fibrillation after coronary artery bypass graft surgery. Cleveland Clinic Journal of Medicine 75(Suppl 2):S44-7.
Offerhaus, R.E. 1980. Heart rate variability in psychiatry. In: RJ Kitney, Rompelman O (eds). The Study of Heart Rate Variability. Oxford: Oxford University Press, 225–238.
Sloan, R.P., Shapiro, P.A., Bigger, T. Jr., Bagiella, E., Steinman, R.C., Gorman, J.M. 1994. Cardiac autonomic control and hostility in healthy subjects. American Journal of Cardiology 74:298–300.
Souza, G.G., Mendoni;a-de-Souza A.C., Barros, E.M., Coutinho, E.F., Oliveira, L., Mendlowicz, M.V., Figueira, I., Volchan, E. 2007. Resilience and vagal tone predict cardiac recovery from acute social stress. Stress 10(4):368-74.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. 1996. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043-65.
Wain, H.J., Amen, D.G., Oetgen, W.J. 1983. Cardiac arrhythmias and hypnotic intervention: advantages, disadvantages, precautions, and theoretical considerations. American Journal of Clinical Hypnosis 26(1):1–4.
Yeragani, V.K., Balon, R., Pohl, R. Ramesh, C., Glitz, D., Weinberg, P., Merlos, B. 1990.
2006 National Survey on Drug Use and Health, Office of Applied Studies. NSDUH Series H-32, DHHS Publication No. SMA 07-4293.
Dopheide, J.A., Pliszka, S.R. 2009. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy. 29(6):656-79.
Hambidge, K.M. Mild zinc deficiency in human subjects. In: Mills, C.F., ed. Zinc in Human Biology. New York: Springer-Verlag. 1989:281-96.
Heo et al. 2008. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer’s disease. European Journal of Neurology 8:865-8.
Jang et al. 2008. Red ginseng for treating erectile dysfunction: a systematic review. British Journal of Clinical Pharmacology 4:444-50.
King, J.C., Cousins, R.J. Zinc. In: Shils, M.E., Shike, M. Ross, A.C., Caballero, B., Cousins, R.J., eds. Modern Nutrition in Health and Disease, 10th ed. Baltimore: Lippincott Williams & Wilkins, 2005:271-85.
Lee et al. 2008. Interactioin between warfarin and Panax ginseng in ischemic stroke patients. Journal of Alternative and Complementary Medicine 6:715-21.
Lee et al. 2008. Panax ginseng enhances cognitive performance in Alzheimer’s disease. Alzheimer Disease & Associated Disorders 3:222-6.
Liang et al. 2005. Panax notoginseng supplementation enhances physical performance during endurance exercise. Journal of Strength & Conditioning Research 1:108-14.
Reay et al. 2005. Single doses of Panax ginseng (GU5) reduce blood glucose levels and improve cognitive performance during sustained mental activity. Journal of Psychopharmacology 4:357-65.
Sotaniemi et al. 1995. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 10:1373-5.
Vuksan et al. 2008 Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism & Cardiovascular Diseases 1:46–56.
Wesnes et al. 2000. The memory enhancing effects of a ginkgo biloba/ panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl.) 4:353-61.